Bio
Hansen Chen, PhD, is an Instructor in the Steinberg Lab at Stanford University School of Medicine. His research investigates the vascular immune-metabolic mechanisms of blood-brain barrier injury after ischemic stroke, with a particular focus on how acute hyperglycemia, complement activation, and endothelial glycocalyx disruption converge to worsen neurovascular damage. By integrating mechanistic mouse models with human stroke samples and clinical biomarker analyses, his work aims to identify therapeutic targets and risk-stratification strategies for stroke patients. He is developing a translational research program centered on the metabolic-complement-vascular (MCV) axis. Beyond the bench, he contributes to stroke science communication through the Stroke journal blog and the AHA Stroke Bridge Webinar Series.
